Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from National Institute of Allergy and Infectious Diseases

How vaccines give our immune systems a home advantage

We are now approaching six years since COVID-19 was declared a pandemic by the World Health Organization, yet talk of vaccines and our immune systems persists in our cultural conversations — from political arenas to the dinner table.

The Conversation

A red meat allergy from tick bites is spreading – and the lone star tick isn’t the only alpha-gal carrier to worry about

Hours after savoring that perfectly grilled steak on a beautiful summer evening, your body turns traitor, declaring war on the very meal you just enjoyed. You begin to feel excruciating itchiness, pain or even swelling that can escalate to the point of requiring emergency care.

The Conversation

Flu: Facts about seasonal influenza and bird flu

Learn interesting facts about the flu, a viral infection that targets the respiratory system.

LiveScience

From analysis to the latest developments in health,
read the most diverse news in one place.

Commentary: For all the good Dr. Fauci did at the NIH, he should have exited the stage sooner

Dr. Anthony Fauci, who began his career at the National Institutes of Health during Lyndon Johnson’s administration, has stepped down as director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to President Joe Biden. To put it in perspective, after more than five decades of…

Chicago Tribune

New Study: Experimental Cancer Vaccine Shows Promise In Animal Trials

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), have reported that an experimental therapeutic cancer vaccine induced two distinct and advantageous immune system responses that resulted in significant tumour regression in mice. Read more on Dynamite News:

Dynamite News

Angry Megyn Kelly drops F-bomb on retiring Dr. Fauci

Conservative broadcaster Megyn Kelly worked blue while talking about retiring National Institute of Allergy and Infectious Diseases director Anthony Fauci on her Wednesday podcast.

Tribune News Service

DeSantis unleashes shocking attack on Fauci saying he wants to see ‘that little elf’ thrown ‘across the Potomac’

Joe Biden’s top medical adviser announced he will leave current job in December

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Thanks, Dr. Fauci, for working to keep us all safe

It’s a wonder Anthony Fauci didn’t throw in the towel earlier. He’s been harassed by countless science deniers and had a boss — Donald Trump —who mocked wearing masks and suggested coronavirus patients be injected with disinfectants.

Chicago Sun-Times

Dr Anthony Fauci, face of US pandemic response, to step down

Joe Biden thanks Fauci, the US president’s chief medical adviser, for his decades of ‘dedicated’ public service.

Al Jazeera

Fauci to step down in December after decades of public service

Dr. Anthony Fauci helped guide the U.S. through the COVID crisis, and earlier in his career played a key role in the response to AIDS. He has served under seven presidents.

WEKU

Fauci to step down in December to ‘pursue next chapter’ of career

Expert, 81, who has led National Institute of Allergy and Infectious Diseases since 1984, clashed with Trump over Covid response

The Guardian - US

Anthony Fauci jokes that he created Covid-19 virus in his own kitchen

Chief medical advisor to the president arrives with Secret Service agents to receive honorary award amid death threats

The Independent UK

Monkeypox and travel: Everything you need to know

‘The first human case of monkeypox was recorded in 1970 in the Democratic Republic of the Congo’ – US National Institute of Allergy and Infectious Diseases

The Independent UK

Dr. Anthony Fauci tests positive for COVID-19, but is experiencing mild symptoms

Fauci, the chief medical adviser to President Biden and director of the National Institute of Allergy and Infectious Diseases, tested positive on a rapid antigen test.

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why NRX Pharmaceuticals Shares Are Trading Lower During Premarket On Thursday?

Based on the review of approximately 460 patients, Data Safety and Monitoring Board (DSMB) determined that the evaluation of NRx Pharmaceuticals Inc's (NASDAQ:NRXP) Zyesami (aviptadil) should cease due to futility. Aviptadil was the sole remaining investigational medicine in ACTIV-3b targeted at critical-ill COVID-19 patients. ACTIV-3b study evaluated Zyesami and Gilead Sciences Inc's (NASDAQ:GILD) Veklury (remdesivir)…

The Independent UK

Covid nasal spray could replace vaccine jabs as scientists rethink fight against virus

A nasal spray could block the transmission of Covid-19, scientists say

The Independent UK

Covid nasal spray could replace vaccine jabs as scientists rethink fight against virus

A nasal spray could block the transmission of Covid-19, scientists say

Businessweek

The Future of Boosters Is Somewhere Between Unnecessary and Urgent

Until there’s a universal coronavirus vaccine, the future of additional shots is a murky work in progress—but more rounds seem increasingly likely.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Moderna Moves Forward With Second HIV Vaccine Trial

Moderna Inc (NASDAQ:MRNA) has dosed the first participant in a clinical trial of an experimental human immunodeficiency virus (HIV) trimer mRNA vaccine (mRNA-1574). The open-label, multicenter, randomized Phase 1 trial (HVTN 302) is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines. The primary hypothesis is that the soluble…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Centers for Disease Control and Prevention

314 stories

Pfizer Inc

312 stories

World Health Organisation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.